Oriola-KD acquired the minority holding of Pfizer in Kronans Droghandel AB
31 August 2006 - Oriola-KD Corporation has increased today its holding in Kronans Droghandel AB (KD) in Sweden from 69.39 per cent to 82.96 per cent after acquiring the minority holdings of Pfizer AB and Pfizer Health AB in KD. Pfizer’s holding in KD was 13.57 per cent (Pfizer AB 12.51 per cent and Pfizer Health AB 1.06 per cent).
The share purchase was paid in cash. Oriola-KD and Pfizer have agreed not to publish the purchase prices of shares. The acquisition in question cannot be deemed significant in accordance with the Rules of the Helsinki Stock Exchange.
The representatives of Pfizer in the Board of Directors of KD, Niklas Prager (member) and Nikolaj Sörensen (deputy member), will resign from the Board of Directors of KD today.
The minority shareholdings after the transactions of shares in KD are divided as follows: Merck Sharp & Dohme Sverige AB 12.51 per cent, Astra Arcus AB 2.66 per cent and Organon AB 1.87 per cent.
Eero Hautaniemi Henry Haarla
President and CEO General Counsel
- Contact Information
- Kimmo Virtanen
- Oriola-KD Corporation
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.